Investing Online

[away]

Cord Blood America, Inc.
(OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation
company which is focused on bringing the life saving potential of stem cells
to families nationwide (http://www.cordpartners.com), today announced that
revenues for the year ended December 31, 2005 increased 51 percent to
$2.28 million compared to revenues of $1.5 million in 2004.
The Company said gross profit increased 48 percent in 2005 to $513,340 and
total assets increased from $334,074 at year-end 2004 to $2.2 million on
December 31, 2005, a 568 percent increase.
"We continue to outpace the industry with our financial performance," said
Chairman and CEO Matthew L. Schissler. "Our success in 2005 was due to
increased marketing efforts, both print media and the Internet, more
consistent communications with prospective customers by telephone, direct mail
and e-mail, the addition of sales people with increased experience, and
importantly an ongoing increase in repeat business and referrals."
Mr. Schissler said the foundation for continued success in 2006 includes
increased strategic referral partnerships with Obstetrics and Gynecology
practices and other healthcare professionals. "Partnering with medical
professionals who work closely with expectant families will further enhance
our long-term growth and profitability," Mr. Schissler said. "We already see
improved results with the increase in customers referred to us by these
physicians."
"We provide families with a convenient and customer friendly storage
option for their child's own rich and abundant source of stem cells.
Umbilical cord blood has emerged as an ideal source for stem cells that may
provide a life-saving option to fighting a multitude of diseases in the
future," Mr. Schissler said. "We are especially proud that our unique pricing
program allows families to bank the umbilical cord blood stem cells without
the major down payment that is required by other programs in the industry."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
Cord Partners, which facilitates umbilical cord blood stem cell preservation
for expectant parents and their children. Its mission is to be the most
respected stem cell preservation company in the industry. Collected through a
safe and non-invasive process, cord blood stem cells offer a powerful and
potentially life-saving resource for treating a growing number of ailments,
including cancer, leukemia, blood, and immune disorders. To find out more
about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website
at Cord Blood America - Cord Blood Preservation and Family Advertising . For more information on how this precious
lifeline can benefit your family, visit our consumer website at
Cord Blood Banking Umbilical Cord Blood Storage .
Forward-Looking Statements
Some statements made in this press release are forward-looking statements,
which are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. We use words such as "anticipate,"
"believe," "expect," "future," "intend," "plan," and similar expressions to
identify forward-looking statements. These statements including those related
to: (i) our ability to outpace the industry with our financial performance,
(ii) whether increased strategic referral partnerships with Obstetrics and
Gynecology practices and other healthcare professionals will contribute to our
success in 2006 (iii) whether Partnering with medical professionals who work
closely with expectant families will further enhance our long-term growth and
profitability, and (iv) whether stem cells will provide a life-saving option
to fight a multitude of diseases in the future, are only predictions and are
subject to certain risks, uncertainties and assumptions. Additional risks are
identified and described in the company's public filings with the Securities
and Exchange Commission. Statements made herein are as of the date of this
press release and should not be relied upon as of any subsequent date. The
company's past performance is not necessarily indicative of its future
performance. The company does not undertake, and the company specifically
disclaims any obligation to update any forward-looking statements to reflect
occurrences, developments, events, or circumstances after the date of such
statement.
CONTACT:
Trevor Bryant
Cord Blood America, Inc.
(310) 432-4090
tbryant@cordpartners.com

Paul Knopick
E & E Communications
(949) 707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.


Contact Information:
Trevor Bryant of Cord Blood America, Inc., +1-310-432-4090, tbryant@cordpartners.com; or Paul Knopick of E & E Communications, +1-949-707-5365, pknopick@eandecommunications.com, for Cord Blood America, Inc.

WebSite:
Cord Blood Banking Umbilical Cord Blood Storage

[{MOD}Napoli]

Cord Blood America Expects Second Quarter Revenues Could Set Record




LOS ANGELES, July 27 /PRNewswire-FirstCall/ -- Cord Blood America, Inc.
(OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation
company which is focused on bringing the life saving potential of stem
cells to families nationwide (http://www.cordpartners.com), today announced
that it expects to file its Second Quarter Form 10-QSB with the U.S.
Securities & Exchange Commission in mid-August.
The Company gave guidance today, saying it expects revenues for the
second quarter ended June 30, 2006, will exceed $900,000 and could be a
record for the Company. Revenues in the same period in 2005 totaled
$665,582. The highest previous quarter was $819,814 in the first quarter of
2005. "We are working with our auditors to get all the financial results to
our shareholders as quickly as possible," said Matthew Schissler, CEO. "As
we announced in May of this year, we experienced record sales figures for
our wholly owned subsidiary, Cord Partners, in the first quarter of 2006.
With our revenue recognition requirements, we are only now beginning to see
the results of that record sales quarter. As more and more families
understand the wisdom in storing umbilical cord blood and, with our
affordable storage plan, we will work hard to continue increasing sales and
revenues significantly."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
Cord Partners, which facilitates umbilical cord blood stem cell
preservation for expectant parents and their children. Its mission is to be
the most respected stem cell preservation company in the industry.
Collected through a safe and non-invasive process, cord blood stem cells
offer a powerful and potentially life-saving resource for treating a
growing number of ailments, including cancer, leukemia, blood, and immune
disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin
Board: CBAI), visit our website at Cord Blood Banking Umbilical Cord Blood Storage. For investor
information, visit Cord Blood America - Cord Blood Preservation and Family Advertising.
Forward-Looking Statements
Some statements made in this press release are forward-looking
statements, which are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. We use words such as
'anticipate,' 'believe,' 'expect,' 'future,' 'intend,' 'plan,' and similar
expressions to identify forward-looking statements. These statements
including those related to the expected quarterly revenue total, the
potential record setting of the second quarter of 2006, the significant
increase of sales and revenues, and the future recognition of first quarter
sales efforts, are only predictions and are subject to certain risks,
uncertainties and assumptions. Additional risks are identified and
described in the company's public filings with the Securities and Exchange
Commission. Statements made herein are as of the date of this press release
and should not be relied upon as of any subsequent date. The company's past
performance is not necessarily indicative of its future performance. The
company does not undertake, and the company specifically disclaims any
obligation to update any forward-looking statements to reflect occurrences,
developments, events, or circumstances after the date of such statement.
CONTACT:
Trevor Bryant
Cord Blood America, Inc.
310/432-4090
tbryant@cordpartners.com

Paul Knopick
E & E Communications
(949) 707-5365
pknopick@eandecommunications.com

[mack24u]

so you thank this would be something worth watching come monday

[{MOD}Napoli]

Originally Posted by mack24u

so you thank this would be something worth watching come monday

Well,chart is looking good except the Dragon Fly Doji on friday.
Monday we gonna know if this stock is ready for reverse imo

[JRW]

CBAI CEO Discusses New Agreements and Cord Blood Bank Industry
(Dec. 18, 2006)
CorCell, the fourth largest private umbilical cord blood bank in the
U.S. and a wholly-owned subsidiary of Cord Blood America Inc. (CBAI),
has entered into a marketing alliance with Highmark Inc., the largest
health insurer in Pennsylvania and Mountain State Blue Cross Blue
Shield (MSBCBS), the largest health insurer in West Virginia.

Through the alliances, CorCell will offer cord blood banking services
directly to Highmark and MSBCBS. Highmark serves 4.6 million people
and MSBCBS provides coverage for more than 425,000 members.

CEO Mark Schissler told Knobias, "This alliance will increases the knowledge and awareness of cord blood banking to MSBCBS and Highmark members through the Plans' education tools and in return, CorCell will offer a preferred price to their members for the cord blood banking services."

A healthy person's stem cells continually replenish their blood and
immune system cells. However, if the body has been decimated by
disease or by medical treatments such as chemotherapy or radiation, new stem
cells are necessary to rebuild the body's blood and immune systems.
Previously the umbilical cord, which contains a rich store of stem
cells, had been thrown away at birth. Cord blood stem cells can now be
collected through a safe and non-invasive process and offer a powerful
and potentially life-saving resource for treating a growing number of
ailments, including leukemia, severe anemia, metabolic blood disorders
and immune deficiencies with many additional uses currently under
investigation in clinical trials.

If a child's cord blood has been stored, there is immediate
availability of matching stem cells for the child, eliminating the
need to search for a suitable bone marrow donor. If another family
member becomes ill with a disease treatable with cord blood stem cells,
there is also a chance that the child's sample may be a match for them
as well. Cord blood stem cells have a better chance of being an
acceptable match because they are immunologically immature and
undeveloped, especially in comparison to other sources of adult stem
cells such as bone marrow or peripheral blood which require a 6 out of 6
tissue match.

Mr.Schissler also noted, "Cord blood transplants have
resulted in a significantly lower incidence of life-threatening side
effects, such as severe graft vs. host disease, which occurs frequently in bone
marrow transplants."

CorCell's PurePathT process protects umbilical cord blood from airborne
contaminants as the UCB is never poured from one container to another,
and ports in the processing and storage bags are never punctured when
processing agents are added, avoiding the possibility of spillage or
exposure to bacteria and viruses in the air. In addition, all CorCell
umbilical cord blood specimens are sterile processed in the company's
private laboratory within Community Blood Services, an American
Association of Blood Banks accredited blood bank located in Bergen
County, N.J.

Corcell CorCell President Marcia Laleman told Knobias, "Our recognized
stem-cell harvesting procedure is preferred by obstetricians for its
safe, simple, uncomplicated method. We arrange for a
specialized medical courier to your hospital room to transport your baby's cord
blood to our processing facility, in a time and temperature controlled
environment. Finally, your baby's cord blood is stored in a recognized,
state-of-the-art, AABB accredited cord blood banking facility that has
successfully transplanted a significant number of cord blood units to
date."

She continued, "CorCell's advantage is its unparalleled expertise in
collecting, transporting, processing and storing umbilical cord blood
stem cells safely and confidentially and our commitment to ongoing
quality improvement with technology such as PurePathT From the birth
of your baby to final storage in our cord blood bank, CorCell gives you
the sense of gives our families the security you they should demand from
a private and personal cord blood bank."

Mr. Schissler concluded, "CorCell's advantage in this market is its
unparalleled expertise in collecting, transporting, processing and
storing umbilical cord blood stem cells safely and confidentially; and
serving the families of our strategic partners, such as Highmark who is
commitment to giving their members a greater hand in their health. From
the birth of your baby to final storage in our cord blood bank, we
provide customers with a sense of security."